These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel vectors for in vivo gene delivery to vascular tissue. White K; Nicklin SA; Baker AH Expert Opin Biol Ther; 2007 Jun; 7(6):809-21. PubMed ID: 17555367 [TBL] [Abstract][Full Text] [Related]
4. Development and use of gene transfer for treatment of cardiovascular disease. Baker AH J Card Surg; 2002; 17(6):543-8. PubMed ID: 12643466 [TBL] [Abstract][Full Text] [Related]
5. Site-specific gene therapy for cardiovascular disease. Fishbein I; Chorny M; Levy RJ Curr Opin Drug Discov Devel; 2010 Mar; 13(2):203-13. PubMed ID: 20205054 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of genes in cardiac repair. Pal SN; Kofidis T Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1015-28. PubMed ID: 23945013 [TBL] [Abstract][Full Text] [Related]
8. Nonviral gene therapy targeting cardiovascular system. Su CH; Wu YJ; Wang HH; Yeh HI Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H629-38. PubMed ID: 22821991 [TBL] [Abstract][Full Text] [Related]
9. Method of gene delivery in large animal models of cardiovascular diseases. Kawase Y; Ladage D; Hajjar RJ Methods Mol Biol; 2011; 709():355-67. PubMed ID: 21194040 [TBL] [Abstract][Full Text] [Related]
10. Vectors for gene therapy of cardiovascular disease. Dedieu JF; Mahfoudi A; Le Roux A; Branellec D Curr Cardiol Rep; 2000 Jan; 2(1):39-47. PubMed ID: 10980871 [TBL] [Abstract][Full Text] [Related]
11. The emerging role of gene therapy in the treatment of cardiovascular diseases. Barbato JE; Kibbe MR; Tzeng E Crit Rev Clin Lab Sci; 2003 Oct; 40(5):499-545. PubMed ID: 14653356 [TBL] [Abstract][Full Text] [Related]
12. Gene delivery to vascular endothelium using chemical vectors: implications for cardiovascular gene therapy. Theoharis S; Manunta M; Tan PH Expert Opin Biol Ther; 2007 May; 7(5):627-43. PubMed ID: 17477801 [TBL] [Abstract][Full Text] [Related]
14. Cell-selective viral gene delivery vectors for the vasculature. Baker AH; Kritz A; Work LM; Nicklin SA Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer and models of gene therapy for the myocardium. Alexander MY; Webster KA; McDonald PH; Prentice HM Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):661-8. PubMed ID: 10499153 [TBL] [Abstract][Full Text] [Related]
16. Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? Dzau VJ Am J Cardiol; 2003 Nov; 92(9B):32N-35N. PubMed ID: 14615024 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Rincon MY; VandenDriessche T; Chuah MK Cardiovasc Res; 2015 Oct; 108(1):4-20. PubMed ID: 26239654 [TBL] [Abstract][Full Text] [Related]
18. Current status of cardiovascular gene therapy. Rissanen TT; Ylä-Herttuala S Mol Ther; 2007 Jul; 15(7):1233-47. PubMed ID: 17505481 [TBL] [Abstract][Full Text] [Related]